Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 635


A Shape Optimization Technique to Predict Left Ventricle Ischemic Tissue Damage.

Dempsey SCH, So A, Samani A.

Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:6124-6127. doi: 10.1109/EMBC.2019.8857800.


Associations of cigarette smoking and burden of thoracic aortic calcification in asymptomatic individuals: A dose-response relationship.

Tsai JP, Jan YT, Yun CH, Sung KT, Liu CC, Kuo JY, Hung CL, Wu TH, Lin JL, Hou CJ, Yeh HI, Bezerra HG, So A.

PLoS One. 2020 Jan 9;15(1):e0227680. doi: 10.1371/journal.pone.0227680. eCollection 2020.


External Societal Costs of Antimicrobial Resistance in Humans Attributable to Antimicrobial Use in Livestock.

Innes GK, Randad PR, Korinek A, Davis MF, Price LB, So AD, Heaney CD.

Annu Rev Public Health. 2020 Jan 7. doi: 10.1146/annurev-publhealth-040218-043954. [Epub ahead of print]


Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.

Pokharel K, Gilbar PJ, Mansfield SK, Nair LM, So A.

J Oncol Pharm Pract. 2019 Dec 15:1078155219893428. doi: 10.1177/1078155219893428. [Epub ahead of print] No abstract available.


Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of renal mass biopsy in the management of kidney cancer.

Lavallée LT, McAlpine K, Kapoor A, Pouliot F, Mason R, Violette PD, Bansal RK, Richard PO, Karakiewicz PI, Bhindi B, Maloni R, Pautler S, Lattouf JB, Kassouf W, Tanguay S, So A, Rendon RA, Breau RH.

Can Urol Assoc J. 2019 Dec;13(12):377-383. doi: 10.5489/cuaj.6176. Epub 2019 Sep 17. No abstract available.


Factors Associated with Postpartum Health Problems among Married Women of Reproductive Age in the Democratic Republic of the Congo: A Cross-sectional Study in Kenge City.

Lee H, So AY, Mansiangi P, Nam EW.

Afr J Reprod Health. 2019 Sep;23(3):30-41. doi: 10.29063/ajrh2019/v23i3.3.


Quantitative low-dose rest and stress CT myocardial perfusion imaging with a whole-heart coverage scanner improves functional assessment of coronary artery disease.

Huang IL, Wu MT, Hu C, Mar GY, Lee TY, So A.

Int J Cardiol Heart Vasc. 2019 Jun 20;24:100381. doi: 10.1016/j.ijcha.2019.100381. eCollection 2019 Sep.


IL1 inhibition in gout-where are we a decade on?

So A.

Arthritis Res Ther. 2019 Nov 11;21(1):233. doi: 10.1186/s13075-019-2027-3. No abstract available.


A Canadian consensus forum on the management of patients with advanced prostate cancer.

Saad F, Canil C, Finelli A, Hotte SJ, Malone S, Shayegan B, So AI, Aaron L, Basappa NS, Conter HJ, Danielson B, Gotto G, Hamilton RJ, Izard JP, Kapoor A, Kolinsky M, Lalani AA, Lattouf JB, Morash C, Morgan SC, Niazi T, Noonan KL, Ong M, Rendon RA, Sehdev S, Hew H, Park-Wyllie L, Chi KN.

Can Urol Assoc J. 2019 Nov 5. doi: 10.5489/cuaj.6082. [Epub ahead of print] Review.


Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma.

Komada H, Hirota Y, So A, Nakamura T, Okuno Y, Fukuoka H, Iguchi G, Takahashi Y, Sakaguchi K, Ogawa W.

Diabetes Metab. 2019 Oct 31. pii: S1262-3636(19)30158-2. doi: 10.1016/j.diabet.2019.10.002. [Epub ahead of print]


Effectiveness of a school-based mental health education program in an impoverished urban area of Peru.

Kim HY, Nam EW, Jin KN, So AY.

Glob Health Promot. 2019 Oct 29:1757975918786728. doi: 10.1177/1757975918786728. [Epub ahead of print]


Targeted knock-in mice expressing the oxidase-fixed form of xanthine oxidoreductase favor tumor growth.

Kusano T, Ehirchiou D, Matsumura T, Chobaz V, Nasi S, Castelblanco M, So A, Lavanchy C, Acha-Orbea H, Nishino T, Okamoto K, Busso N.

Nat Commun. 2019 Oct 28;10(1):4904. doi: 10.1038/s41467-019-12565-z.


Enhanced recovery after surgery (ERAS) protocol reduces perioperative narcotic requirement and length of stay in patients undergoing mastectomy with implant-based reconstruction.

Kennedy GT, Hill CM, Huang Y, So A, Fosnot J, Wu L, Farrar JT, Tchou J.

Am J Surg. 2019 Oct 12. pii: S0002-9610(19)31154-7. doi: 10.1016/j.amjsurg.2019.10.007. [Epub ahead of print]


2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North SA, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, So A, Usmani N, Vigneault E, Chi KN.

Can Urol Assoc J. 2019 Oct;13(10):307-314. doi: 10.5489/cuaj.6136. No abstract available.


Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates.

Nguyen DD, Barber N, Bidair M, Gilling P, Anderson P, Zorn KC, Badlani G, Humphreys M, Kaplan S, Kaufman R, So A, Paterson R, Goldenberg L, Elterman D, Desai M, Lingeman J, Roehrborn C, Bhojani N.

BJU Int. 2020 Jan;125(1):112-122. doi: 10.1111/bju.14917. Epub 2019 Nov 8.


Cubic-Spline Interpolation for Sparse-View CT Image Reconstruction With Filtered Backprojection in Dynamic Myocardial Perfusion Imaging.

Enjilela E, Lee TY, Wisenberg G, Teefy P, Bagur R, Islam A, Hsieh J, So A.

Tomography. 2019 Sep;5(3):300-307. doi: 10.18383/j.tom.2019.00013.


The New York Herald's Very First Report on Dr. Horace Well's Arrest and Suicide-An Original Article Found in New York City Public Library.

So A, Adams D, Pisklakov S.

J Anesth Hist. 2019 Jul;5(3):109-112. doi: 10.1016/j.janh.2018.08.008. Epub 2018 Aug 29.


Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum.

Nappi L, Thi M, Lum A, Huntsman D, Eigl BJ, Martin C, O'Neil B, Maughan BL, Chi K, So A, Black PC, Gleave M, Wyatt AW, Lavoie JM, Khalaf D, Bell R, Daneshmand S, Hamilton RJ, Leao RRN, Nichols C, Kollmannsberger C.

J Clin Oncol. 2019 Nov 20;37(33):3090-3098. doi: 10.1200/JCO.18.02057. Epub 2019 Sep 25.


Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.

Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Sciré C, Pineda C, van Durme C, Lin CT, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Lioté F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea HK, Tupinambá HA, Yamanaka H, Choi HK, Mackay J, ODell JR, Vázquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andrés M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Klück V, Louthrenoo W, Dalbeth N.

Ann Rheum Dis. 2019 Nov;78(11):1592-1600. doi: 10.1136/annrheumdis-2019-215933. Epub 2019 Sep 9.


The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort.

Ankli B, Berger CT, Haeni N, Kyburz D, Hügle T, So AK, Daikeler T.

Swiss Med Wkly. 2019 Sep 2;149:w20121. doi: 10.4414/smw.2019.20121. eCollection 2019 Aug 26.


Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator.

Mannas MP, Lee T, Forbes CM, Hong T, Bisaillon A, Gleave ME, So AI, Mayson K, Black PC.

World J Urol. 2019 Aug 27. doi: 10.1007/s00345-019-02915-3. [Epub ahead of print]


Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.

Kushnir I, Kirk L, Mallick R, Kim RH, Graham GE, Breau RH, Lattouf JB, Violette PD, Pautler SE, Care M, Kapoor A, Jewett MAS, Wood L, Tanguay S, Heng DYC, Basappa NS, So A, Pouliot F, Reaume NM.

Clin Oncol (R Coll Radiol). 2020 Jan;32(1):e10-e15. doi: 10.1016/j.clon.2019.07.010. Epub 2019 Aug 1.


Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer.

Danielson B, Saad F, So A, Morgan S, Hamilton RJ, Malone S, Park-Wyllie L, Zardan A, Shayegan B.

Can Urol Assoc J. 2019 Dec;13(12):420-426. doi: 10.5489/cuaj.5600. Epub 2019 Feb 7. Review.


Outcomes and prognosticators of stage 4 renal cell carcinoma with pathological T4 primary lesion using a large Canadian multi-institutional database.

Oake JD, Patel P, Lavallée LT, Lattouf JB, Saarela O, Klotz L, Moore RB, Kapoor A, Finelli A, Rendon RA, Kawakami J, So A, Drachenberg DE.

Can Urol Assoc J. 2019 Jul 23. doi: 10.5489/cuaj.5941. [Epub ahead of print]


2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC).

Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North S, Pouliot F, Rendon R, Shayegan B, Sridhar S, So A, Usmani N, Vigneault E, Chi KN.

Can Urol Assoc J. 2019 Jun 25. doi: 10.5489/cuaj.6136. [Epub ahead of print] No abstract available.


Renal cell carcinoma in the Canadian Indigenous population.

Wong ECL, Breau RH, Mallick R, Wood L, Pouliot F, Basappa NS, Tanguay S, Soulières D, So A, Heng D, Lavallée LT, Drachenberg D, Kapoor A.

Curr Oncol. 2019 Jun;26(3):e367-e371. doi: 10.3747/co.26.4707. Epub 2019 Jun 1.


Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.

Nayan M, Jalali S, Kapoor A, Finelli A, So A, Rendon R, Breau RH, Lavallee LT, Tanguay S, Heng D, Kawakami J, Basappa NS, Bjarnason G, Pouliot F, Hamilton RJ.

Urol Oncol. 2019 Sep;37(9):576.e11-576.e16. doi: 10.1016/j.urolonc.2019.06.006. Epub 2019 Jul 5.


Validity and Reliability of the Korean Version of the Women's Toileting Behavior Scale.

So A, De Gagne JC, Park S.

Int Neurourol J. 2019 Jun;23(2):151-160. doi: 10.5213/inj.1938018.009. Epub 2019 Jun 30.


The role of the gasotransmitter hydrogen sulfide in pathological calcification.

Castelblanco M, Nasi S, Pasch A, So A, Busso N.

Br J Pharmacol. 2019 Jun 24. doi: 10.1111/bph.14772. [Epub ahead of print] Review.


Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA.

Can Urol Assoc J. 2019 Jun;13(6):166-174. doi: 10.5489/cuaj.5786. No abstract available.


Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2.

Wong ECL, Di Lena R, Breau RH, Pouliot F, Finelli A, Lavallée LT, So A, Tanguay S, Fairey A, Rendon R, Richard PO, Lattouf JB, Kawakami J, Mallick R, Kapoor A.

Urol Oncol. 2019 Oct;37(10):721-726. doi: 10.1016/j.urolonc.2019.05.009. Epub 2019 Jun 5.


An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis.

So A, Inman RD.

Best Pract Res Clin Rheumatol. 2018 Jun;32(3):453-471. doi: 10.1016/j.berh.2018.12.002. Epub 2019 Mar 21. Review.


2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, Coyfish M, Guillo S, Jansen T, Janssens H, Lioté F, Mallen CD, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell A, So AK, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T.

Ann Rheum Dis. 2020 Jan;79(1):31-38. doi: 10.1136/annrheumdis-2019-215315. Epub 2019 Jun 5.


Illicit Cigarette Consumption and Government Revenue Loss in Vietnam: Evidence from a Primary Data Approach.

Nguyen MT, Dao ST, Nguyen NQ, Bowling M, Ross H, So AD.

Int J Environ Res Public Health. 2019 Jun 2;16(11). pii: E1960. doi: 10.3390/ijerph16111960.


Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.

McAlpine K, Lavallée LT, Stacey D, Moodley P, Cagiannos I, Morash C, Black PC, Kulkarni GS, Shayegan B, Kassouf W, Siemens R, So A, Leveridge MJ, Boorjian SA, Daneshmand S, Smith AB, Power N, Izawa J, Drachenberg DE, Fairey A, Rendon RA, Breau RH.

J Urol. 2019 Nov;202(5):1001-1007. doi: 10.1097/JU.0000000000000341. Epub 2019 Oct 9.


Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer.

Li YR, Ro V, Steel L, Carrigan E, Nguyen J, Williams A, So A, Tchou J.

Breast Cancer Res Treat. 2019 Aug;176(3):669-677. doi: 10.1007/s10549-019-05267-z. Epub 2019 May 13.


Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results.

Bhojani N, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Kaplan S, Motola J, Desai M, Roehrborn C.

Urology. 2019 Jul;129:1-7. doi: 10.1016/j.urology.2019.04.029. Epub 2019 May 3.


Management algorithms for metastatic prostate cancer.

Malone S, Shayegan B, Basappa NS, Chi K, Conter HJ, Hamilton RJ, Hotte SJ, Saad F, So A, Park-Wyllie L, Hew H, McLeod D, Gotto G.

Can Urol Assoc J. 2019 Apr 26. doi: 10.5489/cuaj.5840. [Epub ahead of print] Review.


Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.

Raven PA, Lysakowski S, Tan Z, D'Costa NM, Moskalev I, Frees S, Struss W, Matsui Y, Narita S, Buttyan R, Chavez-Munoz C, So AI.

J Cell Physiol. 2019 Nov;234(11):20634-20647. doi: 10.1002/jcp.28669. Epub 2019 Apr 22.


Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy.

Perez-Ruiz F, Jansen TL, Tausche AK, Richette P, Lioté F, So AK, Stack A.

Rheumatol Ther. 2019 Mar;6(1):101-108. doi: 10.1007/s40744-019-0143-9. Epub 2019 Feb 14.


Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trial.

Desai M, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP Jr, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Roehrborn C, Kaplan S, Motola J, Bhojani N.

BJU Int. 2019 Aug;124(2):321-328. doi: 10.1111/bju.14703. Epub 2019 Mar 29.


Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018.

Winthrop KL, Weinblatt ME, Crow MK, Burmester GR, Mease PJ, So AK, Bykerk V, Van Vollenhoven RF, Dougados M, Kay J, Mariette X, Sieper J, Melchers F, Cronstein BN, Shevach E, Breedfeld FC, Kalden J, Smolen JS, Furst DE.

Ann Rheum Dis. 2019 Jul;78(7):872-878. doi: 10.1136/annrheumdis-2018-214280. Epub 2019 Feb 2. Review.


Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.

Raven PA, D'Costa NM, Moskalev I, Tan Z, Frees S, Chavez-Munoz C, So AI.

Am J Clin Exp Urol. 2018 Dec 20;6(6):245-259. eCollection 2018.


Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open-label study (SOAR-KOBE Study).

Miura H, Sakaguchi K, Okada Y, Yamada T, Otowa-Suematsu N, So A, Komada H, Hirota Y, Ohara T, Kuroki Y, Hara K, Matsuda T, Kishi M, Takeda A, Yokota K, Tamori Y, Ogawa W.

J Diabetes Investig. 2019 Sep;10(5):1254-1261. doi: 10.1111/jdi.13015. Epub 2019 Mar 28.


Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.

Vandekerkhove G, Struss WJ, Annala M, Kallio HML, Khalaf D, Warner EW, Herberts C, Ritch E, Beja K, Loktionova Y, Hurtado-Coll A, Fazli L, So A, Black PC, Nykter M, Tammela T, Chi KN, Gleave ME, Wyatt AW.

Eur Urol. 2019 Apr;75(4):667-675. doi: 10.1016/j.eururo.2018.12.042. Epub 2019 Jan 10.


Long-Term Effects of a Self-management Program for Older Women With Urinary Incontinence in Rural Korea: A Comparison Cohort Study.

So A, De Gagne JC, Park S.

J Wound Ostomy Continence Nurs. 2019 Jan/Feb;46(1):55-61. doi: 10.1097/WON.0000000000000498.


Effect of switching from conventional continuous subcutaneous insulin infusion to sensor augmented pump therapy on glycemic profile in Japanese patients with type 1 diabetes.

Matsuoka A, Hirota Y, Urai S, Hamaguchi T, Takeuchi T, Miura H, Suematsu N, So A, Nakamura T, Komada H, Okada Y, Sakaguchi K, Ogawa W.

Diabetol Int. 2018 Jan 22;9(3):201-207. doi: 10.1007/s13340-018-0344-4. eCollection 2018 Jul.


Persistent acidosis after reperfusion-A prognostic indicator of increased 30-day and in-hospital postoperative mortality in liver transplant recipients.

Kim S, DeMaria S Jr, Li J, Lin HM, Smith N, Wax D, Hill B, So A, Tabrizian P, Florman S, Feierman D, Zerillo J.

Clin Transplant. 2019 Mar;33(3):e13473. doi: 10.1111/ctr.13473. Epub 2019 Jan 24.


An Introduction to the Performance of Immunohistochemistry.

Magaki S, Hojat SA, Wei B, So A, Yong WH.

Methods Mol Biol. 2019;1897:289-298. doi: 10.1007/978-1-4939-8935-5_25. Review.

Supplemental Content

Support Center